The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Brabio 40 mg/ml solution for injection in pre-filled syringe

Viatris LimitedPA23266/011/001

Main Information

Trade NameBrabio 40 mg/ml solution for injection in pre-filled syringe
Active SubstancesGlatiramer acetate
Dosage FormSolution for injection in pre-filled syringe
Licence HolderViatris Limited
Licence NumberPA23266/011/001

Group Information

ATC CodeL03AX Other immunostimulants
L03AX13 glatiramer acetate


License statusAuthorised
Licence Issued24/11/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back